Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Thaker

Showing results (231-240 of 237) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 237 results.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2025
Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized studyIgnace Vergote, Larry J Copeland, Toon Van Gorp, et al.
The New England Journal of Medicine|March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine|March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trialRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine|July 25, 2006
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaPremal H Thaker, Liz Y Han, Aparna A Kamat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Gynecologic Oncology|August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancerKoji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Pageof 24

Showing results (231-240 of 237) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 237 results.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2025
Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized studyIgnace Vergote, Larry J Copeland, Toon Van Gorp, et al.
The New England Journal of Medicine|March 27, 2023
Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine|March 5, 2025
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trialRamez N Eskander, Michael W Sill, Lindsey Beffa, et al.
Nature Medicine|July 25, 2006
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinomaPremal H Thaker, Liz Y Han, Aparna A Kamat, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Gynecologic Oncology|August 21, 2019
Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancerKoji Matsuo, James C Cripe, Katherine C Kurnit, et al.
Pageof 24